Correlation Engine 2.0
Clear Search sequence regions


  • adult (1)
  • amniocentesis (2)
  • child (1)
  • dependent (3)
  • diagnosis (4)
  • female (1)
  • fetus (4)
  • gene (5)
  • humans (1)
  • infant (1)
  • mother (2)
  • myelin proteolipid protein (2)
  • PLP1 (9)
  • pregnancy (1)
  • pregnant woman (1)
  • protein human (1)
  • Sizes of these terms reflect their relevance to your search.

    A family with a history of Pelizaeus-Merzbacher disease (PMD) received prenatal diagnosis of PLP1 gene duplication in a fetus using a single nucleotide polymorphism (SNP) array. A 27-year-old pregnant woman was referred for genetic counseling due to her four-year-old son being diagnosed with a suspected classic type of PMD. Amniocentesis was performed at 18 and 3/7 weeks of gestation, and the SNP array was carried out on DNA from the mother, her affected son, and fetus, then further confirmed by multiplex ligation-dependent probe amplification (MLPA). Cytogenetic analysis of the fetus showed 46,XY. SNP array analysis revealed that the male fetus did not carry PLP1 gene duplication but the affected boy did, and the mother was a carrier for the duplication of the PLP1 gene. All SNP array results were further confirmed by MLPA. SNP array and MLPA analyses of peripheral blood verified the nonduplication of the PLP1 gene in the infant after birth. At present, the child (without PLP1 duplication) is developing normally. This study preliminarily suggests that SNP array is a sensitive and accurate technology for identifying PLP1 duplication and is feasible for reliable diagnosis, including for the prenatal diagnosis of PMD resulting from PLP1 duplication.

    Citation

    Huili Xue, Aili Yu, Xuemei Chen, Na Lin, Min Lin, Hailong Huang, Liangpu Xu. Prenatal diagnosis of PLP1 duplication by single nucleotide polymorphism array in a family with Pelizaeus-Merzbacher disease. Aging. 2021 Jan 11;13(1):1488-1497

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 33429367

    View Full Text